The French E3N Cohort Study
www.e3n.fr
www.cesp.inserm.fr
Centre for Research in Epidemiology and Population Health (CESP)
Exposome and Heredity team
INSERM U1018 – Paris Saclay University – Gustave Roussy
https://cesp.inserm.fr/en/equipe/exposome-and-heredity
Each woman in the initial E3N cohort study has been actively followed up by self-administered questionnaires every 2–3 years since 1990; currently, 13 waves of data collection are available, until 2021. These questionnaires collect information on lifestyle and reproductive factors, body size, medical history, and family history of cancer. In addition, women have been passively followed up since 2004 through administrative databases provided by MGEN that include medication claims data and information on medical contacts. Death certificates are available for women who died during follow-up, and linkage to the French National Service on Causes of Death (CépiDC) provided causes of death. Moreover, blood samples were collected from about 25% of the women and saliva samples from almost 50%.
Financial support is provided by:
Investigation of the interplay of exposomic, genetic, and molecular factors in the etiology and prognosis of chronic diseases (in particular cancers, diabetes, and cardiovascular and neurological diseases), examining them both as single entities and as multiple, possibly interconnected conditions (i.e. comorbidities or multimorbidities).